Quantcast
Last updated on April 16, 2014 at 11:49 EDT

Latest research Stories

2014-04-04 23:41:04

Pacifica Graduate Institute, a distinguished, employee-owned university located near Santa Barbara, California is proud to announce an exhibit extension of Carl Jung's artwork. The exhibit has been extended to May 4, 2014 and is free and open to the general public. Santa Barbara, California (PRWEB) April 03, 2014 An exhibition of first-generation fine art prints by Carl G. Jung, taking place at Pacifica Graduate Institute, has been extended due to popular demand. The breathtaking...

2014-04-04 23:34:34

Innovative Adaptive Designs Increase Trial Flexibility and Efficiency, Generating Significant Ethical and Economic Advantages Reston, Virginia (PRWEB) April 03, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of product development, will present emerging strategies for using adaptive trial designs to improve the success...

2014-04-04 23:33:41

MPI’s Drug Response Predictor (DRP) can generate new and unique clinically relevant gene signatures - a strong complementary drug development tool; TD2 is an oncology drug development company that customizes clinical trial design and execution for its customers by applying rigorous and high-throughput translational preclinical development, with best in class regulatory and clinical expertise. Scottsdale, Ariz., USA and Hoersholm, Denmark (PRWEB) April 03, 2014 Medical Prognosis...

2014-04-04 08:25:09

REDWOOD CITY, Calif., April 4, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, and Timothy E. Morris, CFO, will present a Company update on April 9(th). Presentation details are as follows: 13(th) Annual Needham Healthcare Conference Date: Wednesday,...

2014-04-03 20:22:30

DUBLIN, April 4, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ndmgw7/eclinical) has announced the addition of the "eClinical Solutions Market by Products, Services, Buyers & Delivery Modes - Global Forecast to 2018" [http://www.researchandmarkets.com/research/ndmgw7/eclinical ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global eClinical solutions market is estimated to...

2014-04-03 12:35:52

Third Annual Robotics Forum to Address Social, Economic and Entrepreneurial Questions MENLO PARK, Calif., April 3, 2014 /PRNewswire/ -- SRI International will host Xconomy's annual technology forum, Robo Madness, on April 10, 2014, from 1 to 6:30 p.m. at SRI's headquarters in Menlo Park, California. Taking place during National Robotics Week, the event brings together some of the industry's foremost thought leaders to discuss current trends in robotics while exploring the business, social and...

2014-04-03 12:30:25

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management SummaryGBI Research has released the pharma report "Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management". The...

2014-04-03 12:29:55

Great milestones for patient recruitment have been achieved through WCCT Global's Social Media Following COSTA MESA, Calif., April 3, 2014 /PRNewswire-iReach/ -- WCCT Global (WCCTG), a contract research organization headquartered in Southern California announced today that due to their quickly growing Facebook page following of clinical trial volunteers, they now have the ability to directly reach over 240,000 people. The use of social media (SM) for clinical trial patient...

2014-04-02 23:32:53

Cambridge Biomedical Inc. announces that their Chief Operating Officer, Dr. John Reddington, will be attending the 4th annual World Orphan Drug Congress in Washington D.C. April 23-25th, 2014 Boston, MA (PRWEB) April 02, 2014 Cambridge Biomedical’s experience with bioanalytical assay development, optimization, validation and diagnostic testing has proved instrumental in assisting biotechnology and pharmaceutical companies that are focusing on therapies for orphan and ultra-rare disease...

2014-04-02 23:25:23

The new Clinical Conductor CTMS brings enhanced collaborative and financial functionality that make it the most comprehensive CTMS available. Rochester, NY (PRWEB) April 02, 2014 The new Clinical Conductor CTMS is here, and with it comes a revolution in clinical trial collaboration. The industry’s only true collaborative CTMS takes this capability to a new level. The leading financial capabilities of Clinical Conductor have also been strengthened in this release and provide users...